Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the ...

Medicare beneficiaries are also not eligible for Eli Lilly's savings card programs for Zepbound. Jonsson said "in an ideal world," the Trump administration will enact a proposed rule from the ...

Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Eli Lilly has reduced the prices of certain ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access ... were also "priced at a 50% or greater discount compared to the list price of all ...

Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly ... a significant discount, but there's a catch: they can't use their health insurance. Last summer, Lilly started selling ...

Every month, roughly 100,000 people buy Zepbound ... Eli Lilly's CEO. That's about 10% of the 1 million people who use the ...

Last week, Eli Lilly said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is making larger doses available for $499 through its self-pay program.

Record Inventory Increase Meets Growing Consumer Demand for Healthcare Cost-Saving SolutionsSurge Driven by Ozempic and Zepbound Prescription ...

Novo Nordisk’s new offering follows a model that Eli Lilly launched last year, offering vials of its weight-loss drug Zepbound at a discount directly to consumers paying cash. Last week ...